Log in | Register

Home
All Journals
Human Vaccines & Immunotherapeutics
Sections
RSV

Human Vaccines & Immunotherapeutics

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Current issue
All volumes & issues
Special issues
Collections
Most read articles
Most cited articles
Human Vaccines & Immunotherapeutics sections

New content alerts
RSS

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

RSV

Section Editor(s): Ronald Ellis, Biotech and Biopharma, Jerusalem, IL

RSV: research, development, biotechnology, preclinical, clinical, safety, epidemiology, cost, and economics.

Back to Sections

Filters

Show filters

More subjects within No subjects within

Selected filters

Human Vaccines & Immunotherapeutics
RSV

Article (5)
Article Commentary (1)
Method (1)
Other (1)

Last Year (7)
Last 6 Months (4)
Last 3 Months (2)
Last Month (1)

Choose date range:

From:

After year

To:

Before year

Modify your search

Advanced

Search in Where should we search? Search for What are we searching for?

Human Vaccines & Immunotherapeutics sections

Acceptance & Hesitation
Clinical / Regulatory
Communication
Coronavirus
Field Use
Hepatitis
HPV
Immunology
Immunotherapy - Cancer
Immunotherapy - Other
Influenza
Licensed Vaccines
Meningococcal
Novel Vaccines
Passive Immunization
Pneumococcal
Public Health and Policy
Rotavirus
RSV
Technology
Vaccine Safety
Zoster

Showing 1-8 of 8 results for search:

Filters

Modify your search

Select to download all citations or PDFs

Download citations Download PDFs

Order by Relevance
Newest first
Oldest first
Most cited
Most read

Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocolOpen Access
Narmeen Mallah, Sonia Ares-Gómez, Jacobo Pardo-Seco, Alberto Malvar-Pintos, María-Isolina Santiago-Pérez, Olaia Pérez-Martínez, María-Teresa Otero-Barrós, Nuria Suárez-Gaiche, Rolf Kramer, Jing Jin, Leticia Platero-Alonso, Rosa-María Alvárez-Gil, Olga-María Ces-Ozores, Victoria Nartallo-Penas, Susana Mirás-Carballal, Marta Piñeiro-Sotelo, Juan-Manuel González-Pérez, Carmen Rodríguez-Tenreiro, Irene Rivero-Calle, Antonio Salas, Carmen Durán-Parrondo & Federico Martinón-Torres
Human Vaccines & Immunotherapeutics, Volume 20, 2024 - Issue 1
Method | Published online: 13 May 2024 | Views: 346
Full Text
Neutralizing activity of anti-respiratory syncytial virus monoclonal antibody produced in Nicotiana benthamianaOpen Access
Nuttapat Pisuttinusart, Kaewta Rattanapisit, Chanya Srisaowakarn, Arunee Thitithanyanont, Richard Strasser, Balamurugan Shanmugaraj & Waranyoo Phoolcharoen
Human Vaccines & Immunotherapeutics, Volume 20, 2024 - Issue 1
Article | Published online: 20 Mar 2024 | Views: 1303
Full Text
Perceptions about respiratory syncytial virus (RSV) and attitudes toward the RSV vaccine among the general public in China: A cross-sectional surveyOpen Access
Qiang Wang, Shixin Xiu, Liuqing Yang, Lan Li, Min Yang, Xuwen Wang, Yuan Shen, Weibing Wang & Leesa Lin
Human Vaccines & Immunotherapeutics, Volume 20, 2024 - Issue 1
Article | Published online: 18 Feb 2024 | Views: 1599
Full Text
Respiratory syncytial virus knowledge, attitudes, and perceptions among adults in the United StatesOpen Access
Elizabeth M. La, Su Bunniran, Diana Garbinsky, Maria Reynolds, Phil Schwab, Sara Poston & Lauriane Harrington
Human Vaccines & Immunotherapeutics, Volume 20, 2024 - Issue 1
Article | Published online: 31 Jan 2024 | Views: 2557
Full Text
RSV awareness, risk perception, causes, and terms: CommentOpen Access
Somsri Wiwanitkit & Viroj Wiwanitkit
Human Vaccines & Immunotherapeutics, Volume 19, 2023 - Issue 3
Published online: 14 Nov 2023 | Views: 522
Full Text
RSV awareness, risk perception, causes, and terms: Perspectives of pregnant and lactating women in Kenya to inform demand generation efforts for maternal RSV vaccinesOpen Access
Rupali J. Limaye, Berhaun Fesshaye, Prachi Singh & Ruth A. Karron
Human Vaccines & Immunotherapeutics, Volume 19, 2023 - Issue 2
Article | Published online: 09 Oct 2023 | Views: 670 | Citations: 1
Full Text
Respiratory syncytial virus-associated hospitalization in children aged <2 years in Spain from 2018 to 2021Open Access
Enrique Gea-Izquierdo, Ruth Gil-Prieto, Valentín Hernández-Barrera & Ángel Gil-de-Miguel
Human Vaccines & Immunotherapeutics, Volume 19, 2023 - Issue 2
Article | Published online: 12 Jul 2023 | Views: 1206 | Citations: 4
Full Text
Immunization technologies: Time to consider new preventative solutions for respiratory syncytial virus infectionsOpen Access
Catherine Weil-Olivier, David Salisbury, José Antonio Navarro-Alonso, Chryssoula Tzialla, Yan Zhang, Susanna Esposito, Fabio Midulla & Tobias Tenenbaum
Human Vaccines & Immunotherapeutics, Volume 19, 2023 - Issue 1
Article Commentary | Published online: 16 May 2023 | Views: 2499
Full Text

Information for

Authors
R&D professionals
Editors
Librarians
Societies

Open access

Overview
Open journals
Open Select
Dove Medical Press
F1000Research

Opportunities

Reprints and e-prints
Advertising solutions
Accelerated publication
Corporate access solutions

Help and information

Help and contact
Newsroom
All journals
Books

Keep up to date

Register to receive personalised research and resources by email

Taylor and Francis Group Facebook page

Taylor and Francis Group X Twitter page

Taylor and Francis Group Linkedin page

Taylor and Francis Group Youtube page

Taylor and Francis Group Weibo page

Copyright © 2024Informa UK Limited Privacy policy Cookies Terms & conditions Accessibility

Registered in England & Wales No. 3099067
5 Howick Place | London | SW1P 1WG